How many 8-K filings has Goodrx Holdings, Inc. filed?

Goodrx Holdings, Inc. (GDRX) has 20 8-K (Current Event Report) filings on record, spanning Jan 2024 to May 2026.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Goodrx Holdings, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Goodrx Holdings, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Goodrx Holdings, Inc. (GDRX) — 8-K Filings

All 8-K filings from Goodrx Holdings, Inc.. Browse 20 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (20)

8-K Filing — May 6, 2026
8-K Filing — Dec 12, 2025
8-K Filing — Nov 3, 2025
GoodRx Holdings Files 8-K on Shareholder Votes — Jun 4, 2025 Risk: low
GoodRx Holdings, Inc. filed an 8-K on June 4, 2025, reporting on matters submitted to a vote of security holders as of June 3, 2025. The filing details the comp
GoodRx Authorizes $100M Share Buyback Program — Mar 17, 2025 Risk: medium
GoodRx Holdings, Inc. announced on March 16, 2025, that its Board of Directors has authorized a new share repurchase program. The company may repurchase up to $
GoodRx Holdings Announces Director and Executive Changes — Feb 5, 2025 Risk: medium
GoodRx Holdings, Inc. announced on February 4, 2025, changes related to its board of directors and executive compensation. Specifically, the filing details the
GoodRx Holdings, Inc. Announces Board and Executive Changes — Jan 22, 2025 Risk: medium
GoodRx Holdings, Inc. announced on January 21, 2025, changes in its board and executive compensation. Specifically, the company reported the departure of a dire
GoodRx Holdings Announces Board and Executive Changes — Jan 13, 2025 Risk: medium
GoodRx Holdings, Inc. announced on January 7, 2025, changes in its board of directors and executive compensation. The filing details the departure of certain of
GoodRx Holdings Announces Board and Executive Changes — Dec 16, 2024 Risk: low
GoodRx Holdings, Inc. announced on December 12, 2024, changes in its board of directors and executive compensation. The company filed an 8-K detailing the depar
GoodRx Appoints New Directors, Adjusts Executive Pay — Oct 28, 2024 Risk: medium
GoodRx Holdings, Inc. announced on October 22, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two new dir
GoodRx Holdings Amends Credit Agreement — Jul 11, 2024 Risk: medium
On July 10, 2024, GoodRx Holdings, Inc. entered into a material definitive agreement, specifically a Second Amendment to its Credit Agreement. This amendment cr
GoodRx Appoints New Chief Legal Officer — Jul 10, 2024 Risk: low
GoodRx Holdings, Inc. announced on July 8, 2024, the appointment of Steven A. Schaffer as Chief Legal Officer and General Counsel, effective immediately. Schaff
GoodRx Holdings Files 8-K for Shareholder Vote Matters — Jun 7, 2024 Risk: low
On June 6, 2024, GoodRx Holdings, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing indicates that the
GoodRx Appoints New Chief Legal Officer, CLO Departs — May 30, 2024 Risk: medium
GoodRx Holdings, Inc. announced on May 29, 2024, the departure of its Chief Legal Officer, David M. Schottenstein. The company also announced the appointment of
GoodRx CLO Departs, New CLO Appointed — Mar 14, 2024 Risk: medium
GoodRx Holdings, Inc. announced on March 12, 2024, the departure of its Chief Legal Officer, Steven R. Wilson. The company also appointed Laura L. Y. Wu as the
GoodRx Holdings Files 8-K Under 'Other Events' — Mar 7, 2024 Risk: medium
GoodRx Holdings, Inc. filed an 8-K on March 7, 2024, reporting an event that occurred on March 6, 2024. The filing is categorized under 'Other Events' and does
GoodRx CFO Huguet Secures New Employment Agreement — Mar 7, 2024 Risk: low
GoodRx Holdings, Inc. announced on March 4, 2024, that its Chief Financial Officer, Jerome Huguet, has entered into a new employment agreement. The agreement ou
GoodRx Amends Credit Agreement, Appoints Bansi Nagji as New CFO — Feb 26, 2024 Risk: medium
GoodRx Holdings, Inc. entered into a Fifth Amendment to its Credit Agreement on February 20, 2024, with the lenders and administrative agent, modifying certain
GoodRx Director Scott Wagner Resigns from Board, Effective Jan 10 — Jan 17, 2024
GoodRx Holdings, Inc. announced on January 16, 2024, that Scott Wagner resigned from its Board of Directors, effective January 10, 2024. This departure means th
GoodRx Files 8-K on Operations & Financial Condition — Jan 10, 2024
GoodRx Holdings, Inc. filed an 8-K on January 10, 2024, primarily to report on its 'Results of Operations and Financial Condition' and 'Financial Statements and

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX